Ozempic (semaglutide)

Mike Doustdar Novo Nordisk Novo Novo CEO

Fierce Pharma

Novo Nordisk’s ‘optimistic’ CEO Doustdar sits down with Fierce

Novo Nordisk CEO Mike Doustdar told Fierce in an interview that he always believed the Big Pharma “did actually need to become more competitive.”

Fraiser Kansteiner Jun 11, 2026 7:00am

obesity pill

BrightGene's oral drug sees up to 8% weight loss in early data

Mar 25, 2026 4:04am

Diabetes obesity weight loss

Lilly triple-G bet sees 16.8% weight loss in ph. 3 diabetes test

Mar 19, 2026 6:45am

Dark and dramatic sky with sunlight

Skye links CB1-Wegovy combo to 22.3% weight loss after a year

Feb 2, 2026 8:08am

weight loss scale weigh measure tape obesity overweight

Lilly rounds out orforglipron data ahead of obesity filings

Sep 17, 2025 9:00am

Yellow tape measure with a variety of weight loss medication on blue background

Lilly's oral GLP-1 tied to 12% weight loss in phase 3 trial

Aug 7, 2025 6:30am